So far, the associations between clinical prognosis of NSCLC patients and SERPINA1 expression and AAT levels in tumor and adjacent non-tumor tissues as well as serum AAT concentrations have not been reported. This evidence concerns the gene SERPINA1 and non-small cell lung carcinoma.